Qianhai Health Holdings Limited provides earnings guidance for year ended 31 December 2018. The company announced that based on the preliminary review on the management accounts of the Group for the year ended 31 December 2018 and the information currently available to the Board, the Group is to record a decrease in revenue and profit attributable to the Shareholders for the year ended 31 December 2018 as compared to those for the corresponding period in 2017. Such decrease was mainly attributable to the (i) decrease in the trading volume of the American ginseng as the Group keeps a conscious attitude in the trading of American ginseng due to the American ginseng market was volatile in 2018, and (ii) decrease in the average selling price of American ginseng.